Bio Medica Lab

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE1BKA01015
  • NSEID: BMLL
  • BSEID:
INR
104.55
-5.5 (-5.0%)
BSENSE

Jun 02

BSE+NSE Vol: 7000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024

Compare Profit and Loss Results of Bio Medica Lab
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
38.00
112.00
-74.00
-66.07%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
38.00
112.00
-74.00
-66.07%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
-1.00
1.00
100.00%
Raw Materials Consumed
19.00
71.00
-52.00
-73.24%
Power & Fuel Cost
0.00
2.00
-2.00
-100.00%
Employee Cost
1.00
14.00
-13.00
-92.86%
Operating Expenses
0.00
3.00
-3.00
-100.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
8.00
-8.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
5.00
-5.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
22.00
107.00
-85.00
-79.44%
Operating Profit (PBDIT) excl Other Income
15.00
5.00
10.00
200.00%
Other Income
0.00
23.00
-23.00
-100.00%
Operating Profit (PBDIT)
15.00
28.00
-13.00
-46.43%
Interest
1.00
0.00
1.00
0%
Profit before Depriciation and Tax
14.00
28.00
-14.00
-50.00%
Depreciation
1.00
2.00
-1.00
-50.00%
Profit Before Taxation & Exceptional Items
13.00
25.00
-12.00
-48.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
13.00
25.00
-12.00
-48.00%
Provision for Tax
3.00
6.00
-3.00
-50.00%
Profit After Tax
9.00
19.00
-10.00
-52.63%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
4.00
85.00
-81.00
-95.29%
Profit Available for appropriations
14.00
105.00
-91.00
-86.67%
Appropriations
14.00
105.00
-91.00
-86.67%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
10.67
9.42
1.25
13.27%
Profit And Loss - Net Sales
Net Sales 38.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 150.47% vs -6.03% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.21 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 170.15% vs 231.28% in Mar 2024

Profit And Loss - Interest
Interest 1.20 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 23.74% vs 25.05% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 9.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 292.00% vs 649.24% in Mar 2024